Company

About

CuroNZ

CuroNZ

Hamilton, New Zealand

Curonz is a clinical stage biotechnology company with a patent portfolio and a focus on developing Neural Regeneration Peptides (NRPs) for various neurological conditions such as Lennox-Gastaut Syndrome (LGS) and Amyotrophic Lateral Sclerosis (ALS). The company aims to transform the Quality of Life of severely neurologically affected children and adults through its drug candidates.